SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Smithkline Beecham (SBH)
SBH 9.675-0.6%Jul 18 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NucTrader who wrote (44)6/14/1998 5:51:00 PM
From: Henry Niman   of 61
 
SBH has a TZD in trials that should give WLA's Rezulin a real run for the money for treating and preventing type II diabetes. I am most familiar with their alliance with LGND which includes leptin and hematopoietic growth factors. They have discovered small molecules that should replace AMGN's blockbusters, Epogen and Neupogen, and the technology has VERY broad applications (but these products are at a relatively early stage of development - the growth factor mimics have not even started human trials yet.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News